BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pai SG, Carneiro BA, Mota JM, Costa R, Leite CA, Barroso-Sousa R, Kaplan JB, Chae YK, Giles FJ. Wnt/beta-catenin pathway: modulating anticancer immune response. J Hematol Oncol. 2017;10:101. [PMID: 28476164 DOI: 10.1186/s13045-017-0471-6] [Cited by in Crossref: 175] [Cited by in F6Publishing: 181] [Article Influence: 35.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang Y, Xu J, Zhang N, Chen M, Wang H, Zhu D. Targeting the tumour immune microenvironment for cancer therapy in human gastrointestinal malignancies. Cancer Letters 2019;458:123-35. [DOI: 10.1016/j.canlet.2019.05.017] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
2 Nguyen VHL, Hough R, Bernaudo S, Peng C. Wnt/β-catenin signalling in ovarian cancer: Insights into its hyperactivation and function in tumorigenesis. J Ovarian Res 2019;12:122. [PMID: 31829231 DOI: 10.1186/s13048-019-0596-z] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 15.0] [Reference Citation Analysis]
3 Vieira de Castro J, Gomes ED, Granja S, Anjo SI, Baltazar F, Manadas B, Salgado AJ, Costa BM. Impact of mesenchymal stem cells' secretome on glioblastoma pathophysiology. J Transl Med 2017;15:200. [PMID: 28969635 DOI: 10.1186/s12967-017-1303-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
4 Gerard CL, Delyon J, Wicky A, Homicsko K, Cuendet MA, Michielin O. Turning tumors from cold to inflamed to improve immunotherapy response. Cancer Treat Rev 2021;101:102227. [PMID: 34656019 DOI: 10.1016/j.ctrv.2021.102227] [Reference Citation Analysis]
5 Kubo T, Nishimura Y, Sato Y, Yanagihara K, Seyama T. Sixteen Different Types of Lipid-Conjugated siRNAs Containing Saturated and Unsaturated Fatty Acids and Exhibiting Enhanced RNAi Potency. ACS Chem Biol 2021;16:150-64. [PMID: 33346648 DOI: 10.1021/acschembio.0c00847] [Reference Citation Analysis]
6 Chen MH, Gu YY, Zhang AL, Sze DM, Mo SL, May BH. Biological effects and mechanisms of matrine and other constituents of Sophora flavescens in colorectal cancer. Pharmacol Res 2021;171:105778. [PMID: 34298110 DOI: 10.1016/j.phrs.2021.105778] [Reference Citation Analysis]
7 Kozakova K, Mego M, Cheng L, Chovanec M. Promising novel therapies for relapsed and refractory testicular germ cell tumors. Expert Rev Anticancer Ther 2021;21:53-69. [PMID: 33138660 DOI: 10.1080/14737140.2021.1838279] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 He Y, Chen L, Zhao L, Dang S, Liu G, Sasada S, Ma PC, van Zandwijk N, Rosell R, Popper HH, Wang H, Jiang M, Guo H, Liu X, Chen S, Zhang X, Xu M, Zhu B, Liu M, Zhou C. Genomic and transcriptional alterations in first-line chemotherapy exert a potentially unfavorable influence on subsequent immunotherapy in NSCLC. Theranostics 2021;11:7092-109. [PMID: 34093873 DOI: 10.7150/thno.58039] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Gkountakos A, Delfino P, Lawlor RT, Scarpa A, Corbo V, Bria E. Harnessing the epigenome to boost immunotherapy response in non-small cell lung cancer patients. Ther Adv Med Oncol 2021;13:17588359211006947. [PMID: 34104224 DOI: 10.1177/17588359211006947] [Reference Citation Analysis]
10 Li W, Wu H, Xu X, Zhang Y. Comprehensive analysis of genomic and immunological profiles in Chinese and Western hepatocellular carcinoma populations. Aging (Albany NY) 2021;13:11564-94. [PMID: 33867349 DOI: 10.18632/aging.202853] [Reference Citation Analysis]
11 Sun YM, Zheng S, Chen X, Gao F, Zhang J. Lower Nr5a2 Level Downregulates the β-Catenin and TCF-4 Expression in Caerulein-Induced Pancreatic Inflammation. Front Physiol 2019;10:1549. [PMID: 31992986 DOI: 10.3389/fphys.2019.01549] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Jin XF, Spoettl G, Maurer J, Nölting S, Auernhammer CJ. Inhibition of Wnt/β-Catenin Signaling in Neuroendocrine Tumors in vitro: Antitumoral Effects. Cancers (Basel) 2020;12:E345. [PMID: 32033025 DOI: 10.3390/cancers12020345] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
13 El-Ashmawy NE, Al-Ashmawy GM, Fakher HE, Khedr NF. The role of WNT/β-catenin signaling pathway and glutamine metabolism in the pathogenesis of CCl4-induced liver fibrosis: Repositioning of niclosamide and concerns about lithium. Cytokine 2020;136:155250. [PMID: 32882667 DOI: 10.1016/j.cyto.2020.155250] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Wang S, Li Z, Gao S. Key regulators of sensitivity to immunomodulatory drugs in cancer treatment. Biomark Res 2021;9:43. [PMID: 34090534 DOI: 10.1186/s40364-021-00297-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Lyu Q, Jin L, Yang X, Zhang F. LncRNA MINCR activates Wnt/β-catenin signals to promote cell proliferation and migration in oral squamous cell carcinoma. Pathology - Research and Practice 2019;215:924-30. [DOI: 10.1016/j.prp.2019.01.041] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
16 Carreira-Barbosa F, Nunes SC. Wnt Signaling: Paths for Cancer Progression. Adv Exp Med Biol. 2020;1219:189-202. [PMID: 32130700 DOI: 10.1007/978-3-030-34025-4_10] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
17 Zhang J, Zhang X, Yang S, Bao Y, Xu D, Liu L. FOXH1 promotes lung cancer progression by activating the Wnt/β-catenin signaling pathway. Cancer Cell Int 2021;21:293. [PMID: 34090445 DOI: 10.1186/s12935-021-01995-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Sahin IH, Akce M, Alese O, Shaib W, Lesinski GB, El-Rayes B, Wu C. Immune checkpoint inhibitors for the treatment of MSI-H/MMR-D colorectal cancer and a perspective on resistance mechanisms. Br J Cancer 2019;121:809-18. [PMID: 31607751 DOI: 10.1038/s41416-019-0599-y] [Cited by in Crossref: 57] [Cited by in F6Publishing: 45] [Article Influence: 19.0] [Reference Citation Analysis]
19 Maimela NR, Liu S, Zhang Y. Fates of CD8+ T cells in Tumor Microenvironment. Comput Struct Biotechnol J 2019;17:1-13. [PMID: 30581539 DOI: 10.1016/j.csbj.2018.11.004] [Cited by in Crossref: 110] [Cited by in F6Publishing: 106] [Article Influence: 27.5] [Reference Citation Analysis]
20 Zhang W, Sun Z, Su L, Wang F, Jiang Y, Yu D, Zhang F, Sun Z, Liang W. miRNA-185 serves as a prognostic factor and suppresses migration and invasion through Wnt1 in colon cancer. Eur J Pharmacol. 2018;825:75-84. [PMID: 29454608 DOI: 10.1016/j.ejphar.2018.02.019] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 4.8] [Reference Citation Analysis]
21 Bae ES, Kim YM, Kim DH, Byun WS, Park HJ, Chin YW, Lee SK. Anti-Proliferative Activity of Nodosin, a Diterpenoid from Isodon serra, via Regulation of Wnt/β-Catenin Signaling Pathways in Human Colon Cancer Cells. Biomol Ther (Seoul) 2020;28:465-72. [PMID: 32394670 DOI: 10.4062/biomolther.2020.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
22 Jiang J, Jin Z, Zhang Y, Peng L, Zhang Y, Zhu Z, Wang Y, Tong, Yang Y, Wang J, Yang Y, Xiao K. Robust Prediction of Immune Checkpoint Inhibition Therapy for Non-Small Cell Lung Cancer. Front Immunol 2021;12:646874. [PMID: 33927719 DOI: 10.3389/fimmu.2021.646874] [Reference Citation Analysis]
23 Ouseph MM, Taber A, Khurshid H, Madison R, Aswad BI, Resnick MB, Yakirevich E, Ali SM, Patel NR. TKI-resistant ALK-rearranged lung adenocarcinoma with secondary CTNNB1 p.S45V and tertiary ALK p.I1171N mutations. Lung Cancer (Auckl) 2019;10:81-6. [PMID: 31616196 DOI: 10.2147/LCTT.S212406] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
24 Hu W, Li M, Chen Y, Gu X. UBE2S promotes the progression and Olaparib resistance of ovarian cancer through Wnt/β-catenin signaling pathway. J Ovarian Res 2021;14:121. [PMID: 34535173 DOI: 10.1186/s13048-021-00877-y] [Reference Citation Analysis]
25 Yan J, Yang B, Lin S, Xing R, Lu Y. Downregulation of miR-142-5p promotes tumor metastasis through directly regulating CYR61 expression in gastric cancer. Gastric Cancer 2019;22:302-13. [DOI: 10.1007/s10120-018-0872-4] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 6.5] [Reference Citation Analysis]
26 Houschyar KS, Borrelli MR, Rein S, Tapking C, Popp D, Palackic A, Puladi B, Ooms M, Houschyar M, Branski LK, Schmitt L, Modabber A, Rübben A, Hölzle F, Yazdi AS. Head and neck squamous cell carcinoma: a potential therapeutic target for the Wnt signaling pathway. Eur J Plast Surg. [DOI: 10.1007/s00238-022-01958-x] [Reference Citation Analysis]
27 Wan J, Liu Y, Long F, Tian J, Zhang C. circPVT1 promotes osteosarcoma glycolysis and metastasis by sponging miR-423-5p to activate Wnt5a/Ror2 signaling. Cancer Sci 2021;112:1707-22. [PMID: 33369809 DOI: 10.1111/cas.14787] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 Pei Y, Zhang H, Lu K, Tang X, Li J, Zhang E, Zhang J, Huang Y, Yang Z, Lu Z, Li Y, Zhang H, Dong L. Circular RNA circRNA_0067934 promotes glioma development by modulating the microRNA miR-7/ Wnt/β-catenin axis. Bioengineered 2022;13:5792-802. [PMID: 35213267 DOI: 10.1080/21655979.2022.2033382] [Reference Citation Analysis]
29 Gong Q, Jiang Y, Pan X, You Y. Fractalkine aggravates LPS-induced macrophage activation and acute kidney injury via Wnt/β-catenin signalling pathway. J Cell Mol Med 2021;25:6963-75. [PMID: 34101346 DOI: 10.1111/jcmm.16707] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
30 Zeng J, Ma X, Zhao Z, Chen Y, Wang J, Hao Y, Yu J, Zeng Z, Chen N, Zhao M, Tang J, Gong D. Ginsenoside Rb1 Lessens Gastric Precancerous Lesions by Interfering With β-Catenin/TCF4 Interaction. Front Pharmacol 2021;12:682713. [PMID: 34594214 DOI: 10.3389/fphar.2021.682713] [Reference Citation Analysis]
31 Kramer ED, Abrams SI. Granulocytic Myeloid-Derived Suppressor Cells as Negative Regulators of Anticancer Immunity. Front Immunol 2020;11:1963. [PMID: 32983128 DOI: 10.3389/fimmu.2020.01963] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
32 Reddy D, Kumavath R, Tan TZ, Ampasala DR, Kumar AP. Peruvoside targets apoptosis and autophagy through MAPK Wnt/β-catenin and PI3K/AKT/mTOR signaling pathways in human cancers. Life Sci 2020;241:117147. [PMID: 31830480 DOI: 10.1016/j.lfs.2019.117147] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
33 Biondi A, Basile F, Vacante M. Familial adenomatous polyposis and changes in the gut microbiota: New insights into colorectal cancer carcinogenesis. World J Gastrointest Oncol 2021; 13(6): 495-508 [PMID: 34163569 DOI: 10.4251/wjgo.v13.i6.495] [Reference Citation Analysis]
34 Chen W, Sung W, Yu C, Luan Y, Chang Y, Chen S, Lee T. PNU-74654 Suppresses TNFR1/IKB Alpha/p65 Signaling and Induces Cell Death in Testicular Cancer. CIMB 2022;44:222-32. [DOI: 10.3390/cimb44010016] [Reference Citation Analysis]
35 Figueiredo CR, Kalirai H, Sacco JJ, Azevedo RA, Duckworth A, Slupsky JR, Coulson JM, Coupland SE. Loss of BAP1 expression is associated with an immunosuppressive microenvironment in uveal melanoma, with implications for immunotherapy development. J Pathol 2020;250:420-39. [PMID: 31960425 DOI: 10.1002/path.5384] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 17.5] [Reference Citation Analysis]
36 Lin S, Yan Z, Tang Q, Zhang S. Ubiquitin-associated protein 2 like (UBAP2L) enhances growth and metastasis of gastric cancer cells. Bioengineered 2021;12:10232-45. [PMID: 34823423 DOI: 10.1080/21655979.2021.1982308] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Levy D, Reichert CO, Bydlowski SP. Paraoxonases Activities and Polymorphisms in Elderly and Old-Age Diseases: An Overview. Antioxidants (Basel) 2019;8:E118. [PMID: 31052559 DOI: 10.3390/antiox8050118] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
38 Zhang K, Li M, Huang H, Li L, Yang J, Feng L, Gou J, Jiang M, Peng L, Chen L, Li T, Yang P, Yang Y, Wang Y, Peng Q, Dai X, Zhang T. Dishevelled1-3 contribute to multidrug resistance in colorectal cancer via activating Wnt/β-catenin signaling. Oncotarget 2017;8:115803-16. [PMID: 29383202 DOI: 10.18632/oncotarget.23253] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
39 Uram Ł, Markowicz J, Misiorek M, Filipowicz-Rachwał A, Wołowiec S, Wałajtys-Rode E. Celecoxib substituted biotinylated poly(amidoamine) G3 dendrimer as potential treatment for temozolomide resistant glioma therapy and anti-nematode agent. Eur J Pharm Sci 2020;152:105439. [PMID: 32615261 DOI: 10.1016/j.ejps.2020.105439] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Tenghao S, Ning C, Shenghai W, Qinlong S, Jiaqian W, Kuo W, Zhanbiao Y, Xigang M. Keratinocyte Growth Factor-2 Reduces Inflammatory Response to Acute Lung Injury Induced by Oleic Acid in Rats by Regulating Key Proteins of the Wnt/β-Catenin Signaling Pathway. Evid Based Complement Alternat Med 2020;2020:8350579. [PMID: 32655669 DOI: 10.1155/2020/8350579] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
41 Wang F, Zhang Y, Zhou X, Chen X, Xiang J, Fan M, Yu Y, Cai Y, Wu H, Huang S, He N, Hu Z, Ding G, Jin X. Circular RNA CircPPP1CB Suppresses Tumorigenesis by Interacting With the MiR-1307-3p/SMG1 Axis in Human Bladder Cancer. Front Cell Dev Biol 2021;9:704683. [PMID: 34595165 DOI: 10.3389/fcell.2021.704683] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Hosseini F, Alemi F, Malakoti F, Mahmoodpoor A, Younesi S, Yousefi B, Asemi Z. Targeting Wnt/β-catenin signaling by microRNAs as a therapeutic approach in chemoresistant osteosarcoma. Biochem Pharmacol 2021;193:114758. [PMID: 34481813 DOI: 10.1016/j.bcp.2021.114758] [Reference Citation Analysis]
43 Kanaya N, Kuroda S, Kakiuchi Y, Kumon K, Tsumura T, Hashimoto M, Morihiro T, Kubota T, Aoyama K, Kikuchi S, Nishizaki M, Kagawa S, Tazawa H, Mizuguchi H, Urata Y, Fujiwara T. Immune Modulation by Telomerase-Specific Oncolytic Adenovirus Synergistically Enhances Antitumor Efficacy with Anti-PD1 Antibody. Mol Ther 2020;28:794-804. [PMID: 31991110 DOI: 10.1016/j.ymthe.2020.01.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
44 Jearawuttanakul K, Khumkhrong P, Suksen K, Reabroi S, Munyoo B, Tuchinda P, Borwornpinyo S, Boonmuen N, Chairoungdua A. Cleistanthin A induces apoptosis and suppresses motility of colorectal cancer cells. Eur J Pharmacol 2020;889:173604. [PMID: 32980346 DOI: 10.1016/j.ejphar.2020.173604] [Reference Citation Analysis]
45 Jain J, Sutton KS, Hong AL. Progress Update in Pediatric Renal Tumors. Curr Oncol Rep 2021;23:33. [PMID: 33591402 DOI: 10.1007/s11912-021-01016-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Potočnjak I, Šimić L, Gobin I, Vukelić I, Domitrović R. Antitumor activity of luteolin in human colon cancer SW620 cells is mediated by the ERK/FOXO3a signaling pathway. Toxicol In Vitro 2020;66:104852. [PMID: 32268164 DOI: 10.1016/j.tiv.2020.104852] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
47 Betella I, Turbitt WJ, Szul T, Wu B, Martinez A, Katre A, Wall JA, Norian L, Birrer MJ, Arend R. Wnt signaling modulator DKK1 as an immunotherapeutic target in ovarian cancer. Gynecol Oncol 2020;157:765-74. [PMID: 32192732 DOI: 10.1016/j.ygyno.2020.03.010] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
48 Wang Y, Chen Y, Zhu B, Ma L, Xing Q. A Novel Nine Apoptosis-Related Genes Signature Predicting Overall Survival for Kidney Renal Clear Cell Carcinoma and its Associations with Immune Infiltration. Front Mol Biosci 2021;8:567730. [PMID: 33748185 DOI: 10.3389/fmolb.2021.567730] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Hamid AB, Petreaca RC. Secondary Resistant Mutations to Small Molecule Inhibitors in Cancer Cells. Cancers (Basel) 2020;12:E927. [PMID: 32283832 DOI: 10.3390/cancers12040927] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
50 Zhang Y, Wang X. Targeting the Wnt/β-catenin signaling pathway in cancer. J Hematol Oncol 2020;13:165. [PMID: 33276800 DOI: 10.1186/s13045-020-00990-3] [Cited by in Crossref: 36] [Cited by in F6Publishing: 40] [Article Influence: 18.0] [Reference Citation Analysis]
51 Lee JJ, Chu E. Recent Advances in the Clinical Development of Immune Checkpoint Blockade Therapy for Mismatch Repair Proficient (pMMR)/non-MSI-H Metastatic Colorectal Cancer. Clin Colorectal Cancer. 2018;17:258-273. [PMID: 30072278 DOI: 10.1016/j.clcc.2018.06.004] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 6.3] [Reference Citation Analysis]
52 Verhoeven Y, Tilborghs S, Jacobs J, De Waele J, Quatannens D, Deben C, Prenen H, Pauwels P, Trinh XB, Wouters A, Smits EL, Lardon F, van Dam PA. The potential and controversy of targeting STAT family members in cancer. Seminars in Cancer Biology 2020;60:41-56. [DOI: 10.1016/j.semcancer.2019.10.002] [Cited by in Crossref: 43] [Cited by in F6Publishing: 49] [Article Influence: 21.5] [Reference Citation Analysis]
53 Barnawi R, Al-Khaldi S, Bakheet T, Fallatah M, Alaiya A, Ghebeh H, Al-Alwan M. Fascin Activates β-Catenin Signaling and Promotes Breast Cancer Stem Cell Function Mainly Through Focal Adhesion Kinase (FAK): Relation With Disease Progression. Front Oncol 2020;10:440. [PMID: 32373510 DOI: 10.3389/fonc.2020.00440] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
54 Yang L, Li A, Lei Q, Zhang Y. Tumor-intrinsic signaling pathways: key roles in the regulation of the immunosuppressive tumor microenvironment. J Hematol Oncol 2019;12:125. [PMID: 31775797 DOI: 10.1186/s13045-019-0804-8] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 11.0] [Reference Citation Analysis]
55 Sun J, Liu L, Zou H, Yu W. The Long Non-Coding RNA CASC2 Suppresses Cell Viability, Migration, and Invasion in Hepatocellular Carcinoma Cells by Directly Downregulating miR-183. Yonsei Med J 2019;60:905-13. [PMID: 31538425 DOI: 10.3349/ymj.2019.60.10.905] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
56 Sallman DA, Tanaka TN, List A, Bejar R. SOHO State of the Art Update and Next Questions: Biology and Treatment of Myelodysplastic Syndromes. Clin Lymphoma Myeloma Leuk 2017;17:613-20. [PMID: 29025689 DOI: 10.1016/j.clml.2017.09.018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
57 Tóth C, Sükösd F, Valicsek E, Herpel E, Schirmacher P, Tiszlavicz L. Loss of CDX2 gene expression is associated with DNA repair proteins and is a crucial member of the Wnt signaling pathway in liver metastasis of colorectal cancer. Oncol Lett 2018;15:3586-93. [PMID: 29467879 DOI: 10.3892/ol.2018.7756] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
58 Zhang CJ, Zhu N, Wang YX, Liu LP, Zhao TJ, Wu HT, Liao DF, Qin L. Celastrol Attenuates Lipid Accumulation and Stemness of Clear Cell Renal Cell Carcinoma via CAV-1/LOX-1 Pathway. Front Pharmacol 2021;12:658092. [PMID: 33935779 DOI: 10.3389/fphar.2021.658092] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
59 Lu C, He Y, Duan J, Yang Y, Zhong C, Zhang J, Liao W, Huang X, Zhu R, Li M. Expression of Wnt3a in hepatocellular carcinoma and its effects on cell cycle and metastasis. Int J Oncol 2017;51:1135-45. [PMID: 28902357 DOI: 10.3892/ijo.2017.4112] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
60 Mehlman C, Takam Kamga P, Costantini A, Julié C, Dumenil C, Dumoulin J, Ouaknine J, Giraud V, Chinet T, Emile JF, Giroux Leprieur E. Baseline Hedgehog Pathway Activation and Increase of Plasma Wnt1 Protein Are Associated with Resistance to Immune Checkpoint Inhibitors in Advanced Non-Small-Cell Lung Cancer. Cancers (Basel) 2021;13:1107. [PMID: 33807552 DOI: 10.3390/cancers13051107] [Reference Citation Analysis]
61 Yassin NYS, AbouZid SF, El-Kalaawy AM, Ali TM, Almehmadi MM, Ahmed OM. Silybum marianum total extract, silymarin and silibinin abate hepatocarcinogenesis and hepatocellular carcinoma growth via modulation of the HGF/c-Met, Wnt/β-catenin, and PI3K/Akt/mTOR signaling pathways. Biomed Pharmacother 2021;145:112409. [PMID: 34781148 DOI: 10.1016/j.biopha.2021.112409] [Reference Citation Analysis]
62 Costantini A, Julie C, Dumenil C, Hélias-Rodzewicz Z, Tisserand J, Dumoulin J, Giraud V, Labrune S, Chinet T, Emile JF, Giroux Leprieur E. Predictive role of plasmatic biomarkers in advanced non-small cell lung cancer treated by nivolumab. Oncoimmunology 2018;7:e1452581. [PMID: 30221046 DOI: 10.1080/2162402X.2018.1452581] [Cited by in Crossref: 48] [Cited by in F6Publishing: 46] [Article Influence: 12.0] [Reference Citation Analysis]
63 Li LL, Peng Z, Hu Q, Xu LJ, Zou X, Huang DM, Yi P. Berberine retarded the growth of gastric cancer xenograft tumors by targeting hepatocyte nuclear factor 4α. World J Gastrointest Oncol 2022; 14(4): 842-857 [DOI: 10.4251/wjgo.v14.i4.842] [Reference Citation Analysis]
64 Papanagnou P, Papadopoulos GE, Stivarou T, Pappas A. Toward fully exploiting the therapeutic potential of marketed pharmaceuticals: the use of octreotide and chloroquine in oncology. Onco Targets Ther 2019;12:319-39. [PMID: 30643430 DOI: 10.2147/OTT.S182685] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
65 Zhang YL, Liu L, Su YW, Xian CJ. miR-542-3p Attenuates Bone Loss and Marrow Adiposity Following Methotrexate Treatment by Targeting sFRP-1 and Smurf2. Int J Mol Sci 2021;22:10988. [PMID: 34681655 DOI: 10.3390/ijms222010988] [Reference Citation Analysis]
66 Pietrobon V, Marincola FM. Hypoxia and the phenomenon of immune exclusion. J Transl Med 2021;19:9. [PMID: 33407613 DOI: 10.1186/s12967-020-02667-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
67 Singh P, Yadav M, Niveria K, Verma AK. Nano-immunotherapeutics: targeting approach as strategic regulation at tumor microenvironment for cancer treatment. Exploration of Medicine. [DOI: 10.37349/emed.2022.00072] [Reference Citation Analysis]
68 Guo Q, Zhong W, Duan A, Sun G, Cui W, Zhuang X, Liu L. Protective or deleterious role of Wnt/beta-catenin signaling in diabetic nephropathy: An unresolved issue. Pharmacol Res. 2019;144:151-157. [PMID: 30935943 DOI: 10.1016/j.phrs.2019.03.022] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
69 Hu N, Duan JA, Yu Y, Li D, Chen J, Yan H. Sevoflurane inhibits the migration, invasion and induces apoptosis by regulating the expression of WNT1 via miR-637 in colorectal cancer. Anticancer Drugs 2021;32:537-47. [PMID: 33735116 DOI: 10.1097/CAD.0000000000001061] [Reference Citation Analysis]
70 Wang Q, Liao J, He Z, Su Y, Lin D, Xu L, Xu H, Lin J. LHX6 Affects Erlotinib Resistance and Migration of EGFR-Mutant Non-Small-Cell Lung Cancer HCC827 Cells Through Suppressing Wnt/β-Catenin Signaling. Onco Targets Ther 2020;13:10983-94. [PMID: 33149613 DOI: 10.2147/OTT.S258896] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
71 Shen R, Li P, Li B, Zhang B, Feng L, Cheng S. Identification of Distinct Immune Subtypes in Colorectal Cancer Based on the Stromal Compartment. Front Oncol 2019;9:1497. [PMID: 31998649 DOI: 10.3389/fonc.2019.01497] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
72 Haghshenas MR, Ghaderi H, Daneste H, Ghaderi A. Immunological and biological dissection of normal and tumoral salivary glands. Int Rev Immunol 2021;:1-17. [PMID: 34378486 DOI: 10.1080/08830185.2021.1958806] [Reference Citation Analysis]
73 Meyer IS, Leuschner F. The role of Wnt signaling in the healing myocardium: a focus on cell specificity. Basic Res Cardiol 2018;113:44. [PMID: 30327885 DOI: 10.1007/s00395-018-0705-y] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 9.3] [Reference Citation Analysis]
74 Li YJ, Liao LL, Liu P, Tang P, Wang H, Peng QH. Sijunzi Decoction Inhibits Stemness by Suppressing β-Catenin Transcriptional Activity in Gastric Cancer Cells. Chin J Integr Med 2021. [PMID: 34751940 DOI: 10.1007/s11655-021-3314-9] [Reference Citation Analysis]
75 Lizardo DY, Kuang C, Hao S, Yu J, Huang Y, Zhang L. Immunotherapy efficacy on mismatch repair-deficient colorectal cancer: From bench to bedside. Biochim Biophys Acta Rev Cancer 2020;1874:188447. [PMID: 33035640 DOI: 10.1016/j.bbcan.2020.188447] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
76 Guo R, Xing QS. Roles of Wnt Signaling Pathway and ROR2 Receptor in Embryonic Development: An Update Review Article. Genet Epigenet 2022;15:251686572110642. [DOI: 10.1177/25168657211064232] [Reference Citation Analysis]
77 Rosenberg A, Mahalingam D. Immunotherapy in pancreatic adenocarcinoma-overcoming barriers to response. J Gastrointest Oncol. 2018;9:143-159. [PMID: 29564181 DOI: 10.21037/jgo.2018.01.13] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 6.5] [Reference Citation Analysis]
78 Zhou Z, Gong Q, Lin Z, Wang Y, Li M, Wang L, Ding H, Li P. Emerging Roles of SRSF3 as a Therapeutic Target for Cancer. Front Oncol 2020;10:577636. [PMID: 33072610 DOI: 10.3389/fonc.2020.577636] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
79 Sun X, Li K, Zha R, Liu S, Fan Y, Wu D, Hase M, Aryal UK, Lin CC, Li BY, Yokota H. Preventing tumor progression to the bone by induced tumor-suppressing MSCs. Theranostics 2021;11:5143-59. [PMID: 33859739 DOI: 10.7150/thno.58779] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
80 Tong C, Qu K, Wang G, Liu R, Duan B, Wang X, Liu C. Knockdown of DNA-binding protein A enhances the chemotherapy sensitivity of colorectal cancer via suppressing the Wnt/β-catenin/Chk1 pathway. Cell Biol Int 2020;44:2075-85. [PMID: 32652867 DOI: 10.1002/cbin.11416] [Reference Citation Analysis]
81 Berardi S, Corrado A, Maruotti N, Cici D, Cantatore FP. Osteoblast role in the pathogenesis of rheumatoid arthritis. Mol Biol Rep 2021;48:2843-52. [PMID: 33774802 DOI: 10.1007/s11033-021-06288-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
82 Liu B, Chen X, Yi H, Han L, Ji B, Chen H, Deng W, Wan M. β-Catenin is involved in oleanolic acid-dependent promotion of proliferation in human hair matrix cells in an in vitro organ culture model. Fitoterapia 2017;121:136-40. [PMID: 28723343 DOI: 10.1016/j.fitote.2017.07.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
83 Jang J, Song J, Lee H, Sim I, Kwon YV, Jho EH, Yoon Y. LGK974 suppresses lipopolysaccharide-induced endotoxemia in mice by modulating the crosstalk between the Wnt/β-catenin and NF-κB pathways. Exp Mol Med 2021;53:407-21. [PMID: 33692475 DOI: 10.1038/s12276-021-00577-z] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
84 Conway JR, Kofman E, Mo SS, Elmarakeby H, Van Allen E. Genomics of response to immune checkpoint therapies for cancer: implications for precision medicine. Genome Med 2018;10:93. [PMID: 30497521 DOI: 10.1186/s13073-018-0605-7] [Cited by in Crossref: 60] [Cited by in F6Publishing: 51] [Article Influence: 15.0] [Reference Citation Analysis]
85 Yang F, Xu S, Liu R, Shi T, Li X, Li X, Chen G, Liu H, Zhou Q, Chen J. The investigation for potential modifier genes in patients with neurofibromatosis type 1 based on next-generation sequencing. Onco Targets Ther 2018;11:919-32. [PMID: 29503567 DOI: 10.2147/OTT.S156998] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
86 Turrini E, Sestili P, Fimognari C. Overview of the Anticancer Potential of the "King of Spices" Piper nigrum and Its Main Constituent Piperine. Toxins (Basel) 2020;12:E747. [PMID: 33256185 DOI: 10.3390/toxins12120747] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
87 Pashirzad M, Sathyapalan T, Sahebkar A. Clinical Importance of Wnt5a in the Pathogenesis of Colorectal Cancer. J Oncol 2021;2021:3136508. [PMID: 34603445 DOI: 10.1155/2021/3136508] [Reference Citation Analysis]
88 Vaghari-Tabari M, Ferns GA, Qujeq D, Andevari AN, Sabahi Z, Moein S. Signaling, metabolism, and cancer: An important relationship for therapeutic intervention. J Cell Physiol 2021;236:5512-32. [PMID: 33580511 DOI: 10.1002/jcp.30276] [Reference Citation Analysis]
89 Wang Y, Li N, Tian D, Zhou CW, Wang YH, Yang C, Zeng MS. Analysis of m6A-Related lncRNAs for Prognosis Value and Response to Immune Checkpoint Inhibitors Therapy in Hepatocellular Carcinoma. Cancer Manag Res 2021;13:6451-71. [PMID: 34429653 DOI: 10.2147/CMAR.S322179] [Reference Citation Analysis]
90 Zhang L, Lum L. Chemical Modulation of WNT Signaling in Cancer. WNT Signaling in Health and Disease. Elsevier; 2018. pp. 245-69. [DOI: 10.1016/bs.pmbts.2017.11.008] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
91 Niemira M, Collin F, Szalkowska A, Bielska A, Chwialkowska K, Reszec J, Niklinski J, Kwasniewski M, Kretowski A. Molecular Signature of Subtypes of Non-Small-Cell Lung Cancer by Large-Scale Transcriptional Profiling: Identification of Key Modules and Genes by Weighted Gene Co-Expression Network Analysis (WGCNA). Cancers (Basel) 2019;12:E37. [PMID: 31877723 DOI: 10.3390/cancers12010037] [Cited by in Crossref: 50] [Cited by in F6Publishing: 56] [Article Influence: 16.7] [Reference Citation Analysis]
92 Yuan Y, Adam A, Zhao C, Chen H. Recent Advancements in the Mechanisms Underlying Resistance to PD-1/PD-L1 Blockade Immunotherapy. Cancers (Basel) 2021;13:663. [PMID: 33562324 DOI: 10.3390/cancers13040663] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
93 Papp H, Zeghbib S, Földes F, Banfai K, Madai M, Kemenesi G, Urbán P, Kvell K, Jakab F. Crimean-Congo hemorrhagic fever virus infection triggers the upregulation of the Wnt signaling pathway inhibitor genes. Virus Genes 2020;56:508-14. [PMID: 32335793 DOI: 10.1007/s11262-020-01759-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
94 Piazza GA, Ward A, Chen X, Maxuitenko Y, Coley A, Aboelella NS, Buchsbaum DJ, Boyd MR, Keeton AB, Zhou G. PDE5 and PDE10 inhibition activates cGMP/PKG signaling to block Wnt/β-catenin transcription, cancer cell growth, and tumor immunity. Drug Discov Today 2020;25:1521-7. [PMID: 32562844 DOI: 10.1016/j.drudis.2020.06.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
95 Li X, Xiang Y, Li F, Yin C, Li B, Ke X. WNT/β-Catenin Signaling Pathway Regulating T Cell-Inflammation in the Tumor Microenvironment. Front Immunol 2019;10:2293. [PMID: 31616443 DOI: 10.3389/fimmu.2019.02293] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 15.3] [Reference Citation Analysis]
96 Jiang XY, Wang L, Liu ZY, Song WX, Zhou M, Xi L. TMEM48 promotes cell proliferation and invasion in cervical cancer via activation of the Wnt/β-catenin pathway. J Recept Signal Transduct Res 2021;41:371-7. [PMID: 32896205 DOI: 10.1080/10799893.2020.1813761] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
97 Gong R, Chen M, Huang C, Wong HLX, Kwan HY, Bian Z. Combination of artesunate and WNT974 induces KRAS protein degradation by upregulating E3 ligase ANACP2 and β-TrCP in the ubiquitin–proteasome pathway. Cell Commun Signal 2022;20. [DOI: 10.1186/s12964-022-00834-2] [Reference Citation Analysis]
98 Arnaud-Sampaio VF, Rabelo ILA, Bento CA, Glaser T, Bezerra J, Coutinho-Silva R, Ulrich H, Lameu C. Using Cytometry for Investigation of Purinergic Signaling in Tumor-Associated Macrophages. Cytometry A 2020;97:1109-26. [PMID: 32633884 DOI: 10.1002/cyto.a.24035] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
99 Yang L, Tang Y, Xiong F, He Y, Wei F, Zhang S, Guo C, Xiang B, Zhou M, Xie N, Li X, Li Y, Li G, Xiong W, Zeng Z. LncRNAs regulate cancer metastasis via binding to functional proteins. Oncotarget 2018;9:1426-43. [PMID: 29416704 DOI: 10.18632/oncotarget.22840] [Cited by in Crossref: 29] [Cited by in F6Publishing: 39] [Article Influence: 5.8] [Reference Citation Analysis]
100 Bockmayr M, Mohme M, Klauschen F, Winkler B, Budczies J, Rutkowski S, Schüller U. Subgroup-specific immune and stromal microenvironment in medulloblastoma. Oncoimmunology 2018;7:e1462430. [PMID: 30228931 DOI: 10.1080/2162402X.2018.1462430] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 7.3] [Reference Citation Analysis]
101 Rowe M, Krishnan R, Mills A, Ring K. β-catenin and PD-L1 expression in mismatch repair deficient endometrial carcinomas. Int J Gynecol Cancer 2020;30:993-9. [PMID: 32376735 DOI: 10.1136/ijgc-2020-001239] [Reference Citation Analysis]
102 Banerjee A, Chawla-sarkar M, Mukherjee A. Rotavirus-Mediated Suppression of miRNA-192 Family and miRNA-181a Activates Wnt/β-Catenin Signaling Pathway: An In Vitro Study. Viruses 2022;14:558. [DOI: 10.3390/v14030558] [Reference Citation Analysis]
103 Tan SH, Barker N. Wnt Signaling in Adult Epithelial Stem Cells and Cancer. Prog Mol Biol Transl Sci 2018;153:21-79. [PMID: 29389518 DOI: 10.1016/bs.pmbts.2017.11.017] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
104 Hachim MY, Elemam NM, Ramakrishnan RK, Bajbouj K, Olivenstein R, Hachim IY, Al Heialy S, Hamid Q, Busch H, Hamoudi R. Wnt Signaling Is Deranged in Asthmatic Bronchial Epithelium and Fibroblasts. Front Cell Dev Biol 2021;9:641404. [PMID: 33791298 DOI: 10.3389/fcell.2021.641404] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
105 Guo CH, Hsia S, Chung CH, Lin YC, Shih MY, Chen PC, Hsu GW, Fan CT, Peng CL. Combination of Fish Oil and Selenium Enhances Anticancer Efficacy and Targets Multiple Signaling Pathways in Anti-VEGF Agent Treated-TNBC Tumor-Bearing Mice. Mar Drugs 2021;19:193. [PMID: 33805447 DOI: 10.3390/md19040193] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
106 Wu XT, Wang YH, Cai XY, Dong Y, Cui Q, Zhou YN, Yang XW, Lu WF, Zhang M. RNF115 promotes lung adenocarcinoma through Wnt/β-catenin pathway activation by mediating APC ubiquitination. Cancer Metab 2021;9:7. [PMID: 33509267 DOI: 10.1186/s40170-021-00243-y] [Reference Citation Analysis]
107 Olson B, Patnaik A. Utilizing precision medicine to modulate the prostate tumor microenvironment and enhance immunotherapy. Urol Oncol 2019;37:535-42. [PMID: 30503851 DOI: 10.1016/j.urolonc.2018.11.009] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
108 Kim CW, Chon HJ, Kim C. Combination Immunotherapies to Overcome Intrinsic Resistance to Checkpoint Blockade in Microsatellite Stable Colorectal Cancer. Cancers (Basel) 2021;13:4906. [PMID: 34638390 DOI: 10.3390/cancers13194906] [Reference Citation Analysis]
109 Lin Z, He R, Luo H, Lu C, Ning Z, Wu Y, Han C, Tan G, Wang Z. Integrin-β5, a miR-185-targeted gene, promotes hepatocellular carcinoma tumorigenesis by regulating β-catenin stability. J Exp Clin Cancer Res 2018;37:17. [PMID: 29386044 DOI: 10.1186/s13046-018-0691-9] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
110 Li JY, Li XC, Tang YL. Upregulation of miR-128 Mediates Heart Injury by Activating Wnt/β-catenin Signaling Pathway in Heart Failure Mice. Organogenesis 2021;:1-13. [PMID: 34965835 DOI: 10.1080/15476278.2021.2020018] [Reference Citation Analysis]
111 Li JJ, Yang Z, Huang ZS. Progress in basic and clinical research on molecular targeted therapy for primary hepatic carcinoma. Shijie Huaren Xiaohua Zazhi 2019; 27(10): 643-650 [DOI: 10.11569/wcjd.v27.i10.643] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
112 Liu J, Yan J, Yan S, Wang Y, Zhang R, Hou P, He W, Ji M. Biomimetic and Self-Assembled Nanoclusters Targeting β-Catenin for Potent Anticancer Therapy and Enhanced Immunotherapy. Nano Lett 2019;19:8708-15. [DOI: 10.1021/acs.nanolett.9b03414] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
113 Villota H, Röthlisberger S, Pedroza-Díaz J. Modulation of the Canonical Wnt Signaling Pathway by Dietary Polyphenols, an Opportunity for Colorectal Cancer Chemoprevention and Treatment. Nutr Cancer 2021;:1-20. [PMID: 33596716 DOI: 10.1080/01635581.2021.1884730] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
114 Merikhian P, Eisavand MR, Farahmand L. Triple-negative breast cancer: understanding Wnt signaling in drug resistance. Cancer Cell Int 2021;21:419. [PMID: 34376211 DOI: 10.1186/s12935-021-02107-3] [Reference Citation Analysis]
115 Waaler J, Mygland L, Tveita A, Strand MF, Solberg NT, Olsen PA, Aizenshtadt A, Fauskanger M, Lund K, Brinch SA, Lycke M, Dybing E, Nygaard V, Bøe SL, Heintz KM, Hovig E, Hammarström C, Corthay A, Krauss S. Tankyrase inhibition sensitizes melanoma to PD-1 immune checkpoint blockade in syngeneic mouse models. Commun Biol 2020;3:196. [PMID: 32332858 DOI: 10.1038/s42003-020-0916-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
116 Kawasaki A, Namba N, Sada KE, Hirano F, Kobayashi S, Nagasaka K, Sugihara T, Ono N, Fujimoto T, Kusaoi M, Tamura N, Yamagata K, Sumida T, Hashimoto H, Ozaki S, Makino H, Arimura Y, Harigai M, Tsuchiya N. Association of TERT and DSP variants with microscopic polyangiitis and myeloperoxidase-ANCA positive vasculitis in a Japanese population: a genetic association study. Arthritis Res Ther 2020;22:246. [PMID: 33076992 DOI: 10.1186/s13075-020-02347-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
117 Merlano MC, Abbona A, Denaro N, Garrone O. Knowing the tumour microenvironment to optimise immunotherapy. Acta Otorhinolaryngol Ital 2019;39:2-8. [PMID: 30936573 DOI: 10.14639/0392-100X-2481] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
118 Stakheev D, Taborska P, Strizova Z, Podrazil M, Bartunkova J, Smrz D. The WNT/β-catenin signaling inhibitor XAV939 enhances the elimination of LNCaP and PC-3 prostate cancer cells by prostate cancer patient lymphocytes in vitro. Sci Rep 2019;9:4761. [PMID: 30886380 DOI: 10.1038/s41598-019-41182-5] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 8.0] [Reference Citation Analysis]
119 Scholz BA, Sumida N, de Lima CDM, Chachoua I, Martino M, Tzelepis I, Nikoshkov A, Zhao H, Mehmood R, Sifakis EG, Bhartiya D, Göndör A, Ohlsson R. WNT signaling and AHCTF1 promote oncogenic MYC expression through super-enhancer-mediated gene gating. Nat Genet 2019;51:1723-31. [DOI: 10.1038/s41588-019-0535-3] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 6.7] [Reference Citation Analysis]
120 Sarode P, Zheng X, Giotopoulou GA, Weigert A, Kuenne C, Günther S, Friedrich A, Gattenlöhner S, Stiewe T, Brüne B, Grimminger F, Stathopoulos GT, Pullamsetti SS, Seeger W, Savai R. Reprogramming of tumor-associated macrophages by targeting β-catenin/FOSL2/ARID5A signaling: A potential treatment of lung cancer. Sci Adv 2020;6:eaaz6105. [PMID: 32548260 DOI: 10.1126/sciadv.aaz6105] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 9.0] [Reference Citation Analysis]
121 Chen Z. The transrepression and transactivation roles of CtBPs in the pathogenesis of different diseases. J Mol Med (Berl) 2021. [PMID: 34196767 DOI: 10.1007/s00109-021-02107-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
122 Kubo T, Nishimura Y, Hatori Y, Akagi R, Mihara K, Yanagihara K, Seyama T. Antitumor effect of palmitic acid‐conjugated Dsi RNA for colon cancer in a mouse subcutaneous tumor model. Chem Biol Drug Des 2019;93:570-81. [DOI: 10.1111/cbdd.13454] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
123 Hamada T, Soong TR, Masugi Y, Kosumi K, Nowak JA, da Silva A, Mu XJ, Twombly TS, Koh H, Yang J, Song M, Liu L, Gu M, Shi Y, Nosho K, Morikawa T, Inamura K, Shukla SA, Wu CJ, Garraway LA, Zhang X, Wu K, Meyerhardt JA, Chan AT, Glickman JN, Rodig SJ, Freeman GJ, Fuchs CS, Nishihara R, Giannakis M, Ogino S. TIME (Tumor Immunity in the MicroEnvironment) classification based on tumor CD274 (PD-L1) expression status and tumor-infiltrating lymphocytes in colorectal carcinomas. Oncoimmunology 2018;7:e1442999. [PMID: 29900052 DOI: 10.1080/2162402X.2018.1442999] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 7.8] [Reference Citation Analysis]
124 Krutsenko Y, Singhi AD, Monga SP. β-Catenin Activation in Hepatocellular Cancer: Implications in Biology and Therapy. Cancers (Basel) 2021;13:1830. [PMID: 33921282 DOI: 10.3390/cancers13081830] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
125 Kajimoto M, Suzuki K, Ueda Y, Fujimoto K, Takeo T, Nakagata N, Hyuga T, Isono K, Yamada G. Androgen/Wnt/β-catenin signal axis augments cell proliferation of the mouse erectile tissue, corpus cavernosum. Congenit Anom (Kyoto) 2022. [PMID: 35318743 DOI: 10.1111/cga.12465] [Reference Citation Analysis]
126 Braune EB, Seshire A, Lendahl U. Notch and Wnt Dysregulation and Its Relevance for Breast Cancer and Tumor Initiation. Biomedicines 2018;6:E101. [PMID: 30388742 DOI: 10.3390/biomedicines6040101] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
127 Pan X, Lin P, Feng F, Li J, Li Y, Dai W, Hu B, Yang X, Fan J, Li H, Li Y. Comparison of immune profiles between hepatocellular carcinoma subtypes. Biophys Rep 2020;6:19-32. [DOI: 10.1007/s41048-019-00102-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
128 Varricchio A, Ramesh SA, Yool AJ. Novel Ion Channel Targets and Drug Delivery Tools for Controlling Glioblastoma Cell Invasiveness. Int J Mol Sci 2021;22:11909. [PMID: 34769339 DOI: 10.3390/ijms222111909] [Reference Citation Analysis]
129 Yu WK, Xu ZY, Yuan L, Mo S, Xu B, Cheng XD, Qin JJ. Targeting β-Catenin Signaling by Natural Products for Cancer Prevention and Therapy. Front Pharmacol 2020;11:984. [PMID: 32695004 DOI: 10.3389/fphar.2020.00984] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
130 Wang Z, Zhao T, Zhang S, Wang J, Chen Y, Zhao H, Yang Y, Shi S, Chen Q, Liu K. The Wnt signaling pathway in tumorigenesis, pharmacological targets, and drug development for cancer therapy. Biomark Res 2021;9:68. [PMID: 34488905 DOI: 10.1186/s40364-021-00323-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
131 Tan BL, Norhaizan ME. Manilkara zapota (L.) P. Royen leaf water extract triggered apoptosis and activated caspase-dependent pathway in HT-29 human colorectal cancer cell line. Biomed Pharmacother 2019;110:748-57. [PMID: 30554113 DOI: 10.1016/j.biopha.2018.12.027] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
132 Karagiannakos A, Adamaki M, Tsintarakis A, Vojtesek B, Fåhraeus R, Zoumpourlis V, Karakostis K. Targeting Oncogenic Pathways in the Era of Personalized Oncology: A Systemic Analysis Reveals Highly Mutated Signaling Pathways in Cancer Patients and Potential Therapeutic Targets. Cancers 2022;14:664. [DOI: 10.3390/cancers14030664] [Reference Citation Analysis]
133 Liu J, Xiao Q, Xiao J, Niu C, Li Y, Zhang X, Zhou Z, Shu G, Yin G. Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities. Signal Transduct Target Ther 2022;7:3. [PMID: 34980884 DOI: 10.1038/s41392-021-00762-6] [Reference Citation Analysis]
134 Topi S, Santacroce L, Bottalico L, Ballini A, Inchingolo AD, Dipalma G, Charitos IA, Inchingolo F. Gastric Cancer in History: A Perspective Interdisciplinary Study. Cancers (Basel) 2020;12:E264. [PMID: 31978985 DOI: 10.3390/cancers12020264] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
135 Jridi I, Canté-Barrett K, Pike-Overzet K, Staal FJT. Inflammation and Wnt Signaling: Target for Immunomodulatory Therapy? Front Cell Dev Biol 2020;8:615131. [PMID: 33614624 DOI: 10.3389/fcell.2020.615131] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
136 Liu T, Shindel AW, Lin G, Lue TF. Cellular signaling pathways modulated by low-intensity extracorporeal shock wave therapy. Int J Impot Res 2019;31:170-6. [PMID: 30670837 DOI: 10.1038/s41443-019-0113-3] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 9.3] [Reference Citation Analysis]
137 Ganesh S, Shui X, Craig KP, Park J, Wang W, Brown BD, Abrams MT. RNAi-Mediated β-Catenin Inhibition Promotes T Cell Infiltration and Antitumor Activity in Combination with Immune Checkpoint Blockade. Mol Ther 2018;26:2567-79. [PMID: 30274786 DOI: 10.1016/j.ymthe.2018.09.005] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 9.8] [Reference Citation Analysis]
138 Xue C, Li G, Zheng Q, Gu X, Bao Z, Lu J, Li L. The functional roles of the circRNA/Wnt axis in cancer. Mol Cancer 2022;21:108. [PMID: 35513849 DOI: 10.1186/s12943-022-01582-0] [Reference Citation Analysis]
139 Pashirzad M, Johnston TP, Sahebkar A. Therapeutic Effects of Polyphenols on the Treatment of Colorectal Cancer by Regulating Wnt β-Catenin Signaling Pathway. J Oncol 2021;2021:3619510. [PMID: 34621313 DOI: 10.1155/2021/3619510] [Reference Citation Analysis]
140 Soond SM, Zamyatnin AA Jr. Targeting G protein-coupled receptors in cancer therapy. Adv Cancer Res 2020;145:49-97. [PMID: 32089165 DOI: 10.1016/bs.acr.2019.11.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
141 Zhang S, Li M, Xia W, Fan J, Wang J, Li Y, Li Y, Wang H, Dong C, Ma D, Guo J, Peng X. Imaging and Inhibiting: A Dual Function Molecular Flare for Cancer Cells. Anal Chem 2019;91:13501-7. [PMID: 31571476 DOI: 10.1021/acs.analchem.9b02558] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
142 Sanchez-Vega F, Mina M, Armenia J, Chatila WK, Luna A, La KC, Dimitriadoy S, Liu DL, Kantheti HS, Saghafinia S, Chakravarty D, Daian F, Gao Q, Bailey MH, Liang WW, Foltz SM, Shmulevich I, Ding L, Heins Z, Ochoa A, Gross B, Gao J, Zhang H, Kundra R, Kandoth C, Bahceci I, Dervishi L, Dogrusoz U, Zhou W, Shen H, Laird PW, Way GP, Greene CS, Liang H, Xiao Y, Wang C, Iavarone A, Berger AH, Bivona TG, Lazar AJ, Hammer GD, Giordano T, Kwong LN, McArthur G, Huang C, Tward AD, Frederick MJ, McCormick F, Meyerson M, Van Allen EM, Cherniack AD, Ciriello G, Sander C, Schultz N; Cancer Genome Atlas Research Network. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell 2018;173:321-337.e10. [PMID: 29625050 DOI: 10.1016/j.cell.2018.03.035] [Cited by in Crossref: 846] [Cited by in F6Publishing: 740] [Article Influence: 282.0] [Reference Citation Analysis]
143 Liu L, Sun L, Zheng J, Wang Y. Silencing BRIT1 Facilitates the Abilities of Invasiveness and Migration in Trophoblast Cells. Med Sci Monit 2018;24:7451-8. [PMID: 30337515 DOI: 10.12659/MSM.910229] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
144 Pezeshki PS, Mahdavi Sharif P, Rezaei N. Resistance mechanisms to programmed cell death protein 1 and programmed death ligand 1 inhibitors. Expert Opin Biol Ther 2021;:1-16. [PMID: 33984254 DOI: 10.1080/14712598.2021.1929919] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
145 Jeoung NH, Jo AL, Park HS. The effect of autocrine motility factor alone and in combination with methyl jasmonate on liver cancer cell growth. Biosci Biotechnol Biochem 2021;85:1711-5. [PMID: 33988672 DOI: 10.1093/bbb/zbab087] [Reference Citation Analysis]
146 Ruigrok MJR, Frijlink HW, Melgert BN, Olinga P, Hinrichs WLJ. Gene therapy strategies for idiopathic pulmonary fibrosis: recent advances, current challenges, and future directions. Mol Ther Methods Clin Dev 2021;20:483-96. [PMID: 33614824 DOI: 10.1016/j.omtm.2021.01.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
147 Zhang X, Trendowski MR, Wilkinson E, Shahbazi M, Dinh PC, Shuey MM, Feldman DR, Hamilton RJ, Vaughn DJ, Fung C, Kollmannsberger C, Huddart R, Martin NE, Sanchez VA, Frisina RD, Einhorn LH, Cox NJ, Travis LB, Dolan ME; Regeneron Genetics Center. Pharmacogenomics of cisplatin-induced neurotoxicities: Hearing loss, tinnitus, and peripheral sensory neuropathy. Cancer Med 2022. [PMID: 35322580 DOI: 10.1002/cam4.4644] [Reference Citation Analysis]
148 Martin-Orozco E, Sanchez-Fernandez A, Ortiz-Parra I, Ayala-San Nicolas M. WNT Signaling in Tumors: The Way to Evade Drugs and Immunity. Front Immunol 2019;10:2854. [PMID: 31921125 DOI: 10.3389/fimmu.2019.02854] [Cited by in Crossref: 55] [Cited by in F6Publishing: 57] [Article Influence: 18.3] [Reference Citation Analysis]
149 Park AK, Kim P, Ballester LY, Esquenazi Y, Zhao Z. Subtype-specific signaling pathways and genomic aberrations associated with prognosis of glioblastoma. Neuro Oncol 2019;21:59-70. [PMID: 30053126 DOI: 10.1093/neuonc/noy120] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 10.5] [Reference Citation Analysis]
150 Ghosh N, Hossain U, Mandal A, Sil PC. The Wnt signaling pathway: a potential therapeutic target against cancer. Ann N Y Acad Sci. 2019;1443:54-74. [PMID: 31017675 DOI: 10.1111/nyas.14027] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 13.3] [Reference Citation Analysis]
151 Cavalcante RB, Nonaka CFW, Santos HBDP, Rabenhorst SHB, Pereira Pinto L, de Souza LB. Assessment of CTNNB1 gene mutations and β-catenin immunoexpression in salivary gland pleomorphic adenomas and adenoid cystic carcinomas. Virchows Arch 2018;472:999-1005. [DOI: 10.1007/s00428-018-2335-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
152 Wang JC, Li YQ, Feng DY, Zhou X, Yan FQ, Li Y, Gao L, Li LH. Loss of Sfrp2 contributes to the neurological disorders related with morphine withdrawal via Wnt/β-catenin signaling. Behav Brain Res 2019;359:609-18. [PMID: 30291843 DOI: 10.1016/j.bbr.2018.10.005] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
153 Zhou Y, Xu J, Luo H, Meng X, Chen M, Zhu D. Wnt signaling pathway in cancer immunotherapy. Cancer Lett 2022;525:84-96. [PMID: 34740608 DOI: 10.1016/j.canlet.2021.10.034] [Reference Citation Analysis]
154 Milanese JS, Tibiche C, Zou J, Meng Z, Nantel A, Drouin S, Marcotte R, Wang E. Germline variants associated with leukocyte genes predict tumor recurrence in breast cancer patients. NPJ Precis Oncol 2019;3:28. [PMID: 31701019 DOI: 10.1038/s41698-019-0100-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
155 Xu C, Xu Z, Zhang Y, Evert M, Calvisi DF, Chen X. β-Catenin signaling in hepatocellular carcinoma. J Clin Invest 2022;132:e154515. [PMID: 35166233 DOI: 10.1172/JCI154515] [Reference Citation Analysis]
156 Blanc E, Holtgrewe M, Dhamodaran A, Messerschmidt C, Willimsky G, Blankenstein T, Beule D. Identification and ranking of recurrent neo-epitopes in cancer. BMC Med Genomics 2019;12:171. [PMID: 31775766 DOI: 10.1186/s12920-019-0611-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
157 Chen W, Zhao S, Yu W, Rao T, Ruan Y, Zhu S, Xia Y, Song H, Cheng F. SC66 inhibits the proliferation and induces apoptosis of human bladder cancer cells by targeting the AKT/β-catenin pathway. J Cell Mol Med 2021;25:10684-97. [PMID: 34687144 DOI: 10.1111/jcmm.17005] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
158 Wang M, Jiang S, Zhou L, Yu F, Ding H, Li P, Zhou M, Wang K. Potential Mechanisms of Action of Curcumin for Cancer Prevention: Focus on Cellular Signaling Pathways and miRNAs. Int J Biol Sci 2019;15:1200-14. [PMID: 31223280 DOI: 10.7150/ijbs.33710] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 13.0] [Reference Citation Analysis]
159 Alekseeva LI, Byalovsky YY, Zagorodny NV, Ivanova GE, Karateev DE, Konchugova TV, Rakitina IS, Strakhov MA. [Pathophysiological mechanisms of the therapeutic action of alternating electromagnetic fields in the treatment of osteoarticular pathology]. Vopr Kurortol Fizioter Lech Fiz Kult 2021;98:80-90. [PMID: 34223758 DOI: 10.17116/kurort20219803180] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
160 Li X, Chen W, Yang C, Huang Y, Jia J, Xu R, Guan S, Ma R, Yang H, Xie L. IGHG1 upregulation promoted gastric cancer malignancy via AKT/GSK-3β/β-Catenin pathway. Cancer Cell Int 2021;21:397. [PMID: 34315496 DOI: 10.1186/s12935-021-02098-1] [Reference Citation Analysis]
161 Khatun B, Kamath V, Sathyanarayana MB, Pai A, Gupta R, Malviya R. Emerging Role of Wnt/Beta-Catenin Signalling Pathways in Cancer Progression and Role of Small Molecule Tankyrase Inhibitors in Combating Multistage Cancers. CCTR 2021;17:304-11. [DOI: 10.2174/1573394717666210628122306] [Reference Citation Analysis]
162 Bao Y, Cui J, Yue Y, Cao S, Li X, Liu L. ERBB3 binding protein 1 promotes the progression of malignant melanoma through activation of the Wnt/ β-catenin signaling pathway. Cancer Cell Int 2022;22. [DOI: 10.1186/s12935-022-02473-6] [Reference Citation Analysis]
163 Ma Y, Zhang P, Zhang Q, Wang X, Miao Q, Lyu X, Cui B, Ma H. Dihydroartemisinin suppresses proliferation, migration, the Wnt/β-catenin pathway and EMT via TNKS in gastric cancer. Oncol Lett 2021;22:688. [PMID: 34457043 DOI: 10.3892/ol.2021.12949] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
164 Zhang X, Chen R, Song L, Zhu L, Zhan J, Wang F. SIRT6 Promotes the Progression of Prostate Cancer via Regulating the Wnt/β-Catenin Signaling Pathway. Journal of Oncology 2022;2022:1-7. [DOI: 10.1155/2022/2174758] [Reference Citation Analysis]
165 Zhang X, Bai J, Yin H, Long L, Zheng Z, Wang Q, Chen F, Yu X, Zhou Y. Exosomal miR-1255b-5p targets human telomerase reverse transcriptase in colorectal cancer cells to suppress epithelial-to-mesenchymal transition. Mol Oncol 2020;14:2589-608. [PMID: 32679610 DOI: 10.1002/1878-0261.12765] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
166 Wang H, Zhang K, Liu J, Yang J, Tian Y, Yang C, Li Y, Shao M, Su W, Song N. Curcumin Regulates Cancer Progression: Focus on ncRNAs and Molecular Signaling Pathways. Front Oncol 2021;11:660712. [PMID: 33912467 DOI: 10.3389/fonc.2021.660712] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
167 Kolegova ES, Shashova EE, Kostromitskii DN, Dobrodeev AY, Kondakova IV. Beta-Catenin in Non-Small Cells Lung Cancer and Its Association with Proteasomes. Bull Exp Biol Med 2020;168:677-80. [PMID: 32246375 DOI: 10.1007/s10517-020-04779-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
168 Farnsworth DA, Chen YT, de Rappard Yuswack G, Lockwood WW. Emerging Molecular Dependencies of Mutant EGFR-Driven Non-Small Cell Lung Cancer. Cells 2021;10:3553. [DOI: 10.3390/cells10123553] [Reference Citation Analysis]
169 Clara JA, Monge C, Yang Y, Takebe N. Targeting signalling pathways and the immune microenvironment of cancer stem cells - a clinical update. Nat Rev Clin Oncol. 2020;17:204-232. [PMID: 31792354 DOI: 10.1038/s41571-019-0293-2] [Cited by in Crossref: 107] [Cited by in F6Publishing: 118] [Article Influence: 35.7] [Reference Citation Analysis]
170 Doo DW, Meza-Perez S, Londoño AI, Goldsberry WN, Katre AA, Boone JD, Moore DJ, Hudson CT, Betella I, McCaw TR, Gangrade A, Bao R, Luke JJ, Yang ES, Birrer MJ, Starenki D, Cooper SJ, Buchsbaum DJ, Norian LA, Randall TD, Arend RC. Inhibition of the Wnt/β-catenin pathway enhances antitumor immunity in ovarian cancer. Ther Adv Med Oncol 2020;12:1758835920913798. [PMID: 32313567 DOI: 10.1177/1758835920913798] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
171 Zhu Y, Li C, Lin X, Sun J, Cheng Y. [Effect of Atractylodes macrocephala polysaccharide on proliferation and invasion of hepatocellular carcinoma cells in vitro]. Nan Fang Yi Ke Da Xue Xue Bao 2019;39:1180-5. [PMID: 31801717 DOI: 10.12122/j.issn.1673-4254.2019.10.08] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
172 Ideta H, Yoshida K, Okamoto M, Sasaki J, Kito M, Aoki K, Yoshimura Y, Suzuki S, Tanaka A, Takazawa A, Haniu H, Uemura T, Takizawa T, Sobajima A, Kamanaka T, Takahashi J, Kato H, Saito N. Antitumor Effect of Sclerostin against Osteosarcoma. Cancers (Basel) 2021;13:6015. [PMID: 34885123 DOI: 10.3390/cancers13236015] [Reference Citation Analysis]
173 Koujah L, Madavaraju K, Agelidis AM, Patil CD, Shukla D. Heparanase-Induced Activation of AKT Stabilizes β-Catenin and Modulates Wnt/β-Catenin Signaling during Herpes Simplex Virus 1 Infection. mBio 2021;:e0279221. [PMID: 34749529 DOI: 10.1128/mBio.02792-21] [Reference Citation Analysis]
174 Ghafouri-Fard S, Agabalazadeh A, Abak A, Shoorei H, Hassanzadeh Taheri MM, Taheri M, Sharifi G. Role of Long Non-Coding RNAs in Conferring Resistance in Tumors of the Nervous System. Front Oncol 2021;11:670917. [PMID: 34178658 DOI: 10.3389/fonc.2021.670917] [Reference Citation Analysis]
175 Kang HJ, Oh JH, Chun SM, Kim D, Ryu YM, Hwang HS, Kim SY, An J, Cho EJ, Lee H, Shim JH, Sung CO, Yu E. Immunogenomic landscape of hepatocellular carcinoma with immune cell stroma and EBV-positive tumor-infiltrating lymphocytes. J Hepatol 2019;71:91-103. [PMID: 30930222 DOI: 10.1016/j.jhep.2019.03.018] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
176 Qi FF, Yang Y, Zhang H, Chen H. Long non-coding RNAs: Key regulators in oxaliplatin resistance of colorectal cancer. Biomed Pharmacother 2020;128:110329. [PMID: 32502843 DOI: 10.1016/j.biopha.2020.110329] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
177 Starzer AM, Preusser M, Berghoff AS. Immune escape mechanisms and therapeutic approaches in cancer: the cancer-immunity cycle. Ther Adv Med Oncol 2022;14:175883592210962. [DOI: 10.1177/17588359221096219] [Reference Citation Analysis]
178 Maeda K, Kobayashi Y, Koide M, Uehara S, Okamoto M, Ishihara A, Kayama T, Saito M, Marumo K. The Regulation of Bone Metabolism and Disorders by Wnt Signaling. Int J Mol Sci 2019;20:E5525. [PMID: 31698687 DOI: 10.3390/ijms20225525] [Cited by in Crossref: 54] [Cited by in F6Publishing: 50] [Article Influence: 18.0] [Reference Citation Analysis]
179 Sharma U, Murmu M, Barwal TS, Tuli HS, Jain M, Prakash H, Kaceli T, Jain A, Bishayee A. A Pleiotropic Role of Long Non-Coding RNAs in the Modulation of Wnt/β-Catenin and PI3K/Akt/mTOR Signaling Pathways in Esophageal Squamous Cell Carcinoma: Implication in Chemotherapeutic Drug Response. Current Oncology 2022;29:2326-49. [DOI: 10.3390/curroncol29040189] [Reference Citation Analysis]
180 Doussouki ME, Gajjar A, Chamdine O. Molecular genetics of medulloblastoma in children: diagnostic, therapeutic and prognostic implications. Future Neurology 2019;14:FNL8. [DOI: 10.2217/fnl-2018-0030] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 3.7] [Reference Citation Analysis]
181 Gupta N, Srivastava SK. Atovaquone: An Antiprotozoal Drug Suppresses Primary and Resistant Breast Tumor Growth by Inhibiting HER2/β-Catenin Signaling. Mol Cancer Ther 2019;18:1708-20. [PMID: 31270151 DOI: 10.1158/1535-7163.MCT-18-1286] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
182 Lin Q, He Y, Wang X, Zhang Y, Hu M, Guo W, He Y, Zhang T, Lai L, Sun Z, Yi Z, Liu M, Chen Y. Targeting Pyruvate Carboxylase by a Small Molecule Suppresses Breast Cancer Progression. Adv Sci (Weinh) 2020;7:1903483. [PMID: 32382484 DOI: 10.1002/advs.201903483] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
183 Zhao C, Liu Y, Ju S, Wang X. Pan-Cancer Analysis of the N6-Methyladenosine Eraser FTO as a Potential Prognostic and Immunological Biomarker. Int J Gen Med 2021;14:7411-22. [PMID: 34744452 DOI: 10.2147/IJGM.S331752] [Reference Citation Analysis]
184 Zheng H, Ning Y, Yang Y, Zhan Y, Wang H, Wen Q, Peng J, Fan S. Aberrant Expression of β-Catenin Correlates with Infiltrating Immune Cells and Prognosis in NSCLC. Pathol Oncol Res 2021;27:1609981. [PMID: 34764821 DOI: 10.3389/pore.2021.1609981] [Reference Citation Analysis]
185 Chaker M, Minden A, Chen S, Weiss RH, Chini EN, Mahipal A, Azmi AS. Rho GTPase effectors and NAD metabolism in cancer immune suppression. Expert Opin Ther Targets 2018;22:9-17. [PMID: 29207896 DOI: 10.1080/14728222.2018.1413091] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
186 Wu J, Xiao Y, Lu W, Zhang Z, Yang H, Cui X, Wu D, Chen Y, Wang F. Correlation between Tumor Microenvironment and Immune Subtypes Based on CD8 T Cells Enhancing Personalized Therapy of Gastric Cancer. Journal of Oncology 2022;2022:1-23. [DOI: 10.1155/2022/8933167] [Reference Citation Analysis]
187 Zhang J, Zhang S, Li X, Zhang F, Zhao L. HOXB5 promotes the progression of breast cancer through wnt/beta-catenin pathway. Pathol Res Pract 2021;224:153117. [PMID: 34118725 DOI: 10.1016/j.prp.2020.153117] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
188 Xie D, Zhang H, Hu X, Shang C. Knockdown of long non-coding RNA Taurine Up-Regulated 1 inhibited doxorubicin resistance of bladder urothelial carcinoma via Wnt/β-catenin pathway. Oncotarget 2017;8:88689-96. [PMID: 29179467 DOI: 10.18632/oncotarget.20927] [Cited by in Crossref: 17] [Cited by in F6Publishing: 23] [Article Influence: 3.4] [Reference Citation Analysis]
189 Principe N, Kidman J, Goh S, Tilsed CM, Fisher SA, Fear VS, Forbes CA, Zemek RM, Chopra A, Watson M, Dick IM, Boon L, Holt RA, Lake RA, Nowak AK, Lesterhuis WJ, McDonnell AM, Chee J. Tumor Infiltrating Effector Memory Antigen-Specific CD8+ T Cells Predict Response to Immune Checkpoint Therapy. Front Immunol 2020;11:584423. [PMID: 33262762 DOI: 10.3389/fimmu.2020.584423] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
190 Weng J, Xiao J, Mi Y, Fang X, Sun Y, Li S, Qin Z, Li X, Liu T, Zhao S, Zhou L, Wen Y. PCDHGA9 acts as a tumor suppressor to induce tumor cell apoptosis and autophagy and inhibit the EMT process in human gastric cancer. Cell Death Dis 2018;9:27. [PMID: 29348665 DOI: 10.1038/s41419-017-0189-y] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
191 Zang X, Cheng M, Zhang X, Chen X. Quercetin nanoformulations: a promising strategy for tumor therapy. Food Funct 2021;12:6664-81. [PMID: 34152346 DOI: 10.1039/d1fo00851j] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
192 Zhang Y, Song J, Zhao Z, Yang M, Chen M, Liu C, Ji J, Zhu D. Single-cell transcriptome analysis reveals tumor immune microenvironment heterogenicity and granulocytes enrichment in colorectal cancer liver metastases. Cancer Letters 2020;470:84-94. [DOI: 10.1016/j.canlet.2019.10.016] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 12.0] [Reference Citation Analysis]
193 Gajos-Michniewicz A, Czyz M. WNT Signaling in Melanoma. Int J Mol Sci 2020;21:E4852. [PMID: 32659938 DOI: 10.3390/ijms21144852] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 12.0] [Reference Citation Analysis]
194 Alamoud K, Kukuruzinska M. Emerging Insights into Wnt/β-catenin Signaling in Head and Neck Cancer. J Dent Res 2018;97:665-73. [DOI: 10.1177/0022034518771923] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 7.3] [Reference Citation Analysis]
195 Albuquerque C, Pebre Pereira L. Wnt Signalling-Targeted Therapy in the CMS2 Tumour Subtype: A New Paradigm in CRC Treatment? Adv Exp Med Biol 2018;1110:75-100. [PMID: 30623367 DOI: 10.1007/978-3-030-02771-1_6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
196 Sobocińska J, Molenda S, Machnik M, Oleksiewicz U. KRAB-ZFP Transcriptional Regulators Acting as Oncogenes and Tumor Suppressors: An Overview. Int J Mol Sci 2021;22:2212. [PMID: 33672287 DOI: 10.3390/ijms22042212] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
197 Azevedo PL, Oliveira NCA, Corrêa S, Castelo-Branco MTL, Abdelhay E, Binato R. Canonical WNT Signaling Pathway is Altered in Mesenchymal Stromal Cells From Acute Myeloid Leukemia Patients And Is Implicated in BMP4 Down-Regulation. Transl Oncol 2019;12:614-25. [PMID: 30703678 DOI: 10.1016/j.tranon.2019.01.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
198 Wang X, Lu B, Dai C, Fu Y, Hao K, Zhao B, Chen Z, Fu L. Caveolin-1 Promotes Chemoresistance of Gastric Cancer Cells to Cisplatin by Activating WNT/β-Catenin Pathway. Front Oncol 2020;10:46. [PMID: 32117718 DOI: 10.3389/fonc.2020.00046] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
199 Zhao X, Sun Y, Ding Y, Zhang J, Li K. miR-34a Inhibitor May Effectively Protect against Sevoflurane-Induced Hippocampal Apoptosis through the Wnt/β-Catenin Pathway by Targeting Wnt1. Yonsei Med J 2018;59:1205-13. [PMID: 30450855 DOI: 10.3349/ymj.2018.59.10.1205] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
200 Sun Z, Yan K, Liu S, Yu X, Xu J, Liu J, Li S. Semaphorin 3A promotes the osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells in inflammatory environments by suppressing the Wnt/β-catenin signaling pathway. J Mol Histol 2021. [PMID: 33566267 DOI: 10.1007/s10735-020-09941-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
201 Zhang J, Ming C, Zhang W, Okechukwu PN, Morak-Młodawska B, Pluta K, Jeleń M, Akim AM, Ang KP, Ooi KK. 10H-3,6-Diazaphenothiazine induces G2/M phase cell cycle arrest and caspase-dependent apoptosis and inhibits cell invasion of A2780 ovarian carcinoma cells through the regulation of NF-κB and (BIRC6-XIAP) complexes. Drug Des Devel Ther 2017;11:3045-63. [PMID: 29123378 DOI: 10.2147/DDDT.S144415] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 2.4] [Reference Citation Analysis]
202 Farhana L, Banerjee HN, Verma M, Majumdar APN. Role of Microbiome in Carcinogenesis Process and Epigenetic Regulation of Colorectal Cancer. Methods Mol Biol 2018;1856:35-55. [PMID: 30178245 DOI: 10.1007/978-1-4939-8751-1_3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
203 Xu W, He L, Li Y, Tan Y, Zhang F, Xu H. Silencing of lncRNA ZFAS1 inhibits malignancies by blocking Wnt/β-catenin signaling in gastric cancer cells. Biosci Biotechnol Biochem 2018;82:456-65. [PMID: 29424266 DOI: 10.1080/09168451.2018.1431518] [Cited by in Crossref: 44] [Cited by in F6Publishing: 48] [Article Influence: 11.0] [Reference Citation Analysis]
204 Li S, Huang M, Liu Q, Wang D, Wu R, Zhang X, Chen W, Duan L. Serum Expression of β-Catenin Is a Potential Detection Marker in Patients with Colorectal Cancer. Dis Markers 2019;2019:5070524. [PMID: 31781302 DOI: 10.1155/2019/5070524] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
205 Cohen R, Heran M, Pudlarz T, Hilmi M, Tournigand C, André T, Rousseau B. Traitement des cancers colorectaux par immunothérapie : aller au-delà de MSI avec la classification moléculaire (CMS) et la charge mutationnelle. Bulletin du Cancer 2019;106:151-61. [DOI: 10.1016/j.bulcan.2018.09.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
206 Zhu K, Xu W, Han D, Mei X, Khalaf OI. Effect of Sirtuin-1 and Wnt/β-Catenin Signaling Pathway in Rat Model of Spinal Cord Injury. Computational and Mathematical Methods in Medicine 2022;2022:1-7. [DOI: 10.1155/2022/1799607] [Reference Citation Analysis]
207 Haseeb M, Pirzada RH, Ain QU, Choi S. Wnt Signaling in the Regulation of Immune Cell and Cancer Therapeutics. Cells 2019;8:E1380. [PMID: 31684152 DOI: 10.3390/cells8111380] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 7.7] [Reference Citation Analysis]
208 Zhang XC, Wang J, Shao GG, Wang Q, Qu X, Wang B, Moy C, Fan Y, Albertyn Z, Huang X, Zhang J, Qiu Y, Platero S, Lorenzi MV, Zudaire E, Yang J, Cheng Y, Xu L, Wu YL. Comprehensive genomic and immunological characterization of Chinese non-small cell lung cancer patients. Nat Commun 2019;10:1772. [PMID: 30992440 DOI: 10.1038/s41467-019-09762-1] [Cited by in Crossref: 58] [Cited by in F6Publishing: 72] [Article Influence: 19.3] [Reference Citation Analysis]
209 Zhang Y, Zu D, Chen Z, Ying G. An update on Wnt signaling pathway in cancer. Transl Cancer Res 2020;9:1246-52. [PMID: 35117469 DOI: 10.21037/tcr.2019.12.50] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
210 Trabucco SE, Gowen K, Maund SL, Sanford E, Fabrizio DA, Hall MJ, Yakirevich E, Gregg JP, Stephens PJ, Frampton GM, Hegde PS, Miller VA, Ross JS, Hartmaier RJ, Huang SA, Sun JX. A Novel Next-Generation Sequencing Approach to Detecting Microsatellite Instability and Pan-Tumor Characterization of 1000 Microsatellite Instability-High Cases in 67,000 Patient Samples. J Mol Diagn 2019;21:1053-66. [PMID: 31445211 DOI: 10.1016/j.jmoldx.2019.06.011] [Cited by in Crossref: 58] [Cited by in F6Publishing: 44] [Article Influence: 19.3] [Reference Citation Analysis]
211 Khalyfa AA, Punatar S, Aslam R, Yarbrough A. Exploring the Inflammatory Pathogenesis of Colorectal Cancer. Diseases 2021;9:79. [PMID: 34842660 DOI: 10.3390/diseases9040079] [Reference Citation Analysis]
212 Cai X, Tao W, Li L. Glioma cell-derived FGF20 suppresses macrophage function by activating β-catenin. Cell Signal 2022;89:110181. [PMID: 34757019 DOI: 10.1016/j.cellsig.2021.110181] [Reference Citation Analysis]
213 Uddin MB, Wang Z, Yang C. The m6A RNA methylation regulates oncogenic signaling pathways driving cell malignant transformation and carcinogenesis. Mol Cancer 2021;20:61. [PMID: 33814008 DOI: 10.1186/s12943-021-01356-0] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
214 Banik D, Moufarrij S, Villagra A. Immunoepigenetics Combination Therapies: An Overview of the Role of HDACs in Cancer Immunotherapy. Int J Mol Sci 2019;20:E2241. [PMID: 31067680 DOI: 10.3390/ijms20092241] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 15.7] [Reference Citation Analysis]
215 Humphries B, Wang Z, Yang C. MicroRNA Regulation of Breast Cancer Stemness. Int J Mol Sci 2021;22:3756. [PMID: 33916548 DOI: 10.3390/ijms22073756] [Reference Citation Analysis]
216 Nie J, Jiang HC, Zhou YC, Jiang B, He WJ, Wang YF, Dong J. MiR-125b regulates the proliferation and metastasis of triple negative breast cancer cells via the Wnt/β-catenin pathway and EMT. Biosci Biotechnol Biochem 2019;83:1062-71. [PMID: 30950326 DOI: 10.1080/09168451.2019.1584521] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 3.7] [Reference Citation Analysis]
217 Boughanem H, Cabrera-Mulero A, Hernández-Alonso P, Clemente-Postigo M, Casanueva FF, Tinahones FJ, Morcillo S, Crujeiras AB, Macias-Gonzalez M. Association between variation of circulating 25-OH vitamin D and methylation of secreted frizzled-related protein 2 in colorectal cancer. Clin Epigenetics 2020;12:83. [PMID: 32517740 DOI: 10.1186/s13148-020-00875-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
218 Gonçalves CS, Xavier-Magalhães A, Martins EP, Pinto AA, Pires MM, Pinheiro C, Reis RM, Sousa N, Costa BM. A novel molecular link between HOXA9 and WNT6 in glioblastoma identifies a subgroup of patients with particular poor prognosis. Mol Oncol 2020;14:1224-41. [PMID: 31923345 DOI: 10.1002/1878-0261.12633] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
219 Ding S, Qu W, Jiao Y, Zhang J, Zhang C, Dang S. LncRNA SNHG12 promotes the proliferation and metastasis of papillary thyroid carcinoma cells through regulating wnt/β-catenin signaling pathway. CBM 2018;22:217-26. [DOI: 10.3233/cbm-170777] [Cited by in Crossref: 43] [Cited by in F6Publishing: 24] [Article Influence: 10.8] [Reference Citation Analysis]
220 Li X, Zhang M, Yu X, Xue M, Li X, Ma C, Jia W, Gao Q, Kang C, Pan J. AHCYL1 Is a Novel Biomarker for Predicting Prognosis and Immunotherapy Response in Colorectal Cancer. Journal of Oncology 2022;2022:1-13. [DOI: 10.1155/2022/5054324] [Reference Citation Analysis]